As on Wednesday, Arcadia Biosciences Inc (NASDAQ: RKDA) got off with the flyer as it spiked 31.36% to $4.44, before settling in for the price of $3.38 at the close. Taking a more long-term approach, RKDA posted a 52-week range of $2.53-$10.31.
The company of the Consumer Defensive sector’s yearbook sales growth during the past 5- year span was recorded 50.91%. Meanwhile, its Annual Earning per share during the time was 50.91%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 19.24%. This publicly-traded company’s shares outstanding now amounts to $1.37 million, simultaneously with a float of $1.36 million. The organization now has a market capitalization sitting at $6.07 million. At the time of writing, stock’s 50-day Moving Average stood at $3.85, while the 200-day Moving Average is $4.18.
Arcadia Biosciences Inc (RKDA) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Packaged Foods industry. Arcadia Biosciences Inc’s current insider ownership accounts for 0.82%, in contrast to 4.33% institutional ownership. According to the most recent insider trade that took place on Feb 03 ’25, this organization’s Chief Financial Officer bought 700 shares at the rate of 2.49, making the entire transaction reach 1,743 in total value, affecting insider ownership by 2,681. Preceding that transaction, on Feb 03 ’25, Company’s Chief Executive Officer bought 700 for 2.49, making the whole transaction’s value amount to 1,743. This particular insider is now the holder of 2,819 in total.
Arcadia Biosciences Inc (RKDA) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.66 per share during the current fiscal year.
Arcadia Biosciences Inc’s EPS increase for this current 12-month fiscal period is 19.24% and is forecasted to reach -2.42 in the upcoming year.
Arcadia Biosciences Inc (NASDAQ: RKDA) Trading Performance Indicators
Let’s observe the current performance indicators for Arcadia Biosciences Inc (RKDA). It’s Quick Ratio in the last reported quarter now stands at 3.31. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.12.
In the same vein, RKDA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -5.52, a figure that is expected to reach -0.54 in the next quarter, and analysts are predicting that it will be -2.42 at the market close of one year from today.
Technical Analysis of Arcadia Biosciences Inc (RKDA)
Through scrutinizing the latest numbers posted by the [Arcadia Biosciences Inc, RKDA], it can be observed that its last 5-days Average volume of 1.25 million was better the volume of 43114.0, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 42.17% While, its Average True Range was 79.93.
Raw Stochastic average of Arcadia Biosciences Inc (RKDA) in the period of the previous 100 days is set at 40.65%, which indicates a major rise in contrast to 35.25% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.39 that was higher than 0.28 volatility it exhibited in the past 100-days period.
